53 results on '"Farzaneh-Far, Ramin"'
Search Results
2. Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial
3. Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody–Positive Generalized Myasthenia Gravis
4. Cross‐sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatment
5. Comparison of the Quantitative Myasthenia Gravis (QMG) and Myasthenia Gravis Activities of Daily Living (MG-ADL) scores in the MGTX Randomized Trial (P2.2-102)
6. Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis
7. Body mass index is negatively associated with telomere length: a collaborative cross-sectional meta-analysis of 87 observational studies
8. RA101495, A Subcutaneously Administered Peptide Inhibitor of Complement Component 5 (C5) for the Treatment of Generalized Myasthenia Gravis (gMG): Phase 1 Results and Phase 2 Design (S31.006)
9. The spectrum of complement C9 staining in lupus nephritis
10. Correction: Change in Leukocyte Telomere Length Predicts Mortality in Patients with Stable Coronary Heart Disease from the Heart and Soul Study
11. Change in Leukocyte Telomere Length Predicts Mortality in Patients with Stable Coronary Heart Disease from the Heart and Soul Study
12. Occurrence of Clinically Diagnosed Hypertrophic Cardiomyopathy in the United States
13. SP322A DRUG-DRUG INTERACTION STUDY TO EVALUATE THE EFFECT OF VADADUSTAT ON THE PHARMACOKINETICS OF CELECOXIB, A CYP2C9 SUBSTRATE IN HEALTHY VOLUNTEERS
14. Novel Approach Targeting the Complex Pathophysiology of Hypertrophic Cardiomyopathy
15. Long-Term Outcome of Incomplete Revascularization After Percutaneous Coronary Intervention in SCAAR (Swedish Coronary Angiography and Angioplasty Registry)
16. Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization
17. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial
18. Effects of Ranolazine in Patients With Chronic Angina in Patients With and Without Percutaneous Coronary Intervention for Acute Coronary Syndrome: Observations From the MERLIN-TIMI 36 Trial
19. Association of Cardiorespiratory Fitness With Left Ventricular Remodeling and Diastolic Function
20. Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: Design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post–Percutaneous Coronary Intervention (RIVER-PCI) trial
21. Physical Fitness and Risk for Heart Failure and Coronary Artery Disease
22. THE ANTI-ISCHEMIC EFFECT OF RANOLAZINE CLOSELY PARALLELS ITS QTC-SHORTENING EFFECT IN PATIENTS WITH LONG-QT SYNDROME 3
23. Dysfunctional Adiposity and the Risk of Prediabetes and Type 2 Diabetes in Obese Adults
24. Hydroxychloroquine: A Treatable Cause of Cardiomyopathy
25. Association Between Leukocyte Telomere Length and Drug-Eluting Stent Strut Coverage by Optical Coherence Tomography
26. Abstract 299: Association of Chronic Lung Disease with Treatments and Outcomes of Acute Coronary Syndromes: Results from the NCDR®
27. PROGNOSTIC SIGNIFICANCE OF INTERMEDIATE QRS DURATION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
28. CORRELATION BETWEEN LEUKOCYTE TELOMERE LENGTH AND DRUG ELUTING STENT STRUT COVERAGE BY OPTICAL COHERENCE TOMOGRAPHY
29. Physical Fitness and Telomere Length in Patients with Coronary Heart Disease: Findings from the Heart and Soul Study
30. Abstract P280: Leptin is Associated With Lower Mortality in Patients With Stable Coronary Artery Disease: The Heart and Soul Study
31. Abstract P213: Association Between Depression and Leukocyte Telomere Length in Patients With Stable Coronary Heart Disease: Data From the Heart and Soul Study
32. Depression and Leukocyte Telomere Length in Patients With Coronary Heart Disease
33. Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: The Heart and Soul Study
34. Relation of Whole Blood n-3 Fatty Acid Levels to Exercise Parameters in Patients With Stable Coronary Artery Disease (from the Heart and Soul Study)
35. Prognostic value of electrocardiographic detection of unrecognized myocardial infarction in persons with stable coronary artery disease: data from the Heart and Soul Study
36. Association of blood pressure and heart rate response during exercise with cardiovascular events in the Heart and Soul Study
37. A Functional Polymorphism in Renalase (Glu37Asp) Is Associated with Cardiac Hypertrophy, Dysfunction, and Ischemia: Data from the Heart and Soul Study
38. Surgical Timing in Infectious Endocarditis
39. Association of Marine Omega-3 Fatty Acid Levels With Telomeric Aging in Patients With Coronary Heart Disease
40. Telomere Length Trajectory and Its Determinants in Persons with Coronary Artery Disease: Longitudinal Findings from the Heart and Soul Study
41. Relation of β-Blocker Use With Frequency of Hospitalization for Heart Failure in Patients With Left Ventricular Diastolic Dysfunction (from the Heart and Soul Study)
42. Relation of Obesity to Heart Failure Hospitalization and Cardiovascular Events in Persons With Stable Coronary Heart Disease (from the Heart and Soul Study)
43. Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study
44. Authors’ reply: Lack of association of chromosome 9p21.3 genotype with cardiovascular function in persons with stable coronary artery disease: The Heart and Soul Study
45. Lack of association of chromosome 9p21.3 genotype with cardiovascular structure and function in persons with stable coronary artery disease: The Heart and Soul Study
46. Left-Ventricular Power-to-Mass Ratio at Peak Exercise Predicts Mortality, Heart Failure, and Cardiovascular Events in Patients with Stable Coronary Artery Disease: Data from the Heart and Soul Study
47. Development of an Echocardiographic Risk-Stratification Index to Predict Heart Failure in Patients With Stable Coronary Artery Disease
48. Prognostic Value of Leukocyte Telomere Length in Patients With Stable Coronary Artery Disease
49. Usefulness of Noninvasive Estimate of Pulmonary Vascular Resistance to Predict Mortality, Heart Failure, and Adverse Cardiovascular Events in Patients With Stable Coronary Artery Disease (from the Heart and Soul Study)
50. Left Atrial Dimension in Stress Echocardiography
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.